Mexico castrate resistant prostate cancer market statistics, by therapy, 2016-2027 (USD Million)
Mexico castrate-resistant prostate cancer market size was valued at 32.3 USD million in 2017 and is estimated to grow at a compound annual growth rate (CAGR) of 11% from 2018 to 2027.